Table 1.
Characteristic | Value |
---|---|
Age, median (IQR), y | 61 (15) |
Female sex | 66 (58%) |
Race | |
White | 97 (86%) |
Black | 4 (3.5%) |
Asian/Pacific Islander | 9 (8.0%) |
Hispanic or Latino | 3 (2.7%) |
BMI, median (IQR), kg/m2 | 28 (9) |
No. of comorbidities | |
0 | 19 (17%) |
1 | 30 (27%) |
2 | 35 (31%) |
≥ 3 | 29 (25%) |
Smoking status | |
Never | 35 (31%) |
Former | 51 (45%) |
Current | 27 (24%) |
Pack-years, median (IQR), ya | 27 (35) |
Years since quit, median (IQR)b | 16 (20) |
Personal history of extrathoracic malignancy | 10 (8.9%) |
Personal history of thoracic radiation therapy | 4 (3.5%) |
Family history of lung cancer | 25 (22%) |
Previous imaging available | 38 (34%) |
Indication for CT imagingc | |
Chest radiographic abnormality | 35 (31%) |
Cough | 26 (23%) |
Dyspnea | 24 (21%) |
Chest pain | 14 (12%) |
Other | 45 (40%) |
Nodule characteristicsd | |
Size | |
Median (IQR), mm | 8 (13) |
≤ 4 mm | 20 (18%) |
> 4-6 mm | 22 (20%) |
> 6-8 mm | 17 (15%) |
> 8 mm | 54 (48%) |
More than 1 nodule | 69 (61%) |
Density | |
Solid | 98 (88%) |
Partially solid | 12 (11%) |
Ground-glass opacity | 3 (2.7%) |
Spiculated | 29 (26%) |
Lobar location of nodule | |
Upper lobes | 58 (51%) |
Lower lobes | 47 (42%) |
Spans multiple lobes | 1 (0.88%) |
Not reported | 7 (6.2%) |
Year | |
2010 | 39 (35%) |
2011 | 39 (35%) |
2012 | 35 (31%) |
Median follow-up (IQR), ye | 4.4 (1.8) |
IQR = interquartile range.
Among 78 current or former smokers.
Among 51 former smokers.
Columns may not add to 100% because patients may have multiple conditions or indications.
Refers to the dominant nodule.
Follow-up < 3 years is due to death.